Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948102 · ClinicalTrials.gov registry record
Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 132
- Enrollment target
NCT01948102 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 132 participants.
The verdict
NCT01948102 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The purpose of the project is to obtain skin and adipose tissue samples from patients with ALS to develop new diagnostic and prognostic markers of the disease. These samples will be obtained when percutaneous endoscopic gastrostomy (PEG) is performed as part of their standard of care. Skin and adipose tissue samples will also be obtained from disease control subjects who require a PEG as part of their standard of care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2008-08-20 |
| Est. Completion | 2017-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948102
The ClinicalTrials.gov registry entry for NCT01948102 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01948102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948102 about?
NCT01948102 is a clinical study titled "Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples". The purpose of the project is to obtain skin and adipose tissue samples from patients with ALS to develop new diagnostic and prognostic markers of the disease. These samples will be obtained when percutaneous endoscopic gastrostomy (PEG) is performed as part of their standard of care. Skin and adipo...
What is the current status of trial NCT01948102?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2008-08-20. Estimated completion is 2017-04-04.
Who is sponsoring clinical trial NCT01948102?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.